Article
Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.
The Journal of clinical endocrinology and metabolism - 1 Jan 2011
Faucz Fabio Rueda, Horvath Anelia, Rothenbuhler Anya, Almeida Madson Q, Libé Rossella, Raffin-Sanson Marie-Laure, Bertherat Jerome, Carraro Dirce Maria, Soares Fernando Augusto, Molina Gustavo de Campos, Campos Antonio H, Alexandre Rodrigo B, Bendhack Marcelo Luiz, Nesterova Maria, Stratakis Constantine A
Abstract excerpt
CONTEXT: Among the genomic loci harboring potential candidate genes for prostatic cancer (PCa) is the 2q31-33 chromosomal region that harbors the gene encoding phosphodiesterase 11A (PDE11A). In addition, the combined cancer genome expression metaanalysis datasets included PDE11A among the top 1% down-regulated genes in PCa. OBJECTIVE: In the present study, we screened 50 unrelated PCa patients of Brazilian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
